{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:12:42Z","timestamp":1776132762399,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970526"],"award-info":[{"award-number":["81970526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100639"],"award-info":[{"award-number":["82100639"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["JYZZ162"],"award-info":[{"award-number":["JYZZ162"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejphar.2023.176278","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T02:34:35Z","timestamp":1703644475000},"page":"176278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats"],"prefix":"10.1016","volume":"964","author":[{"given":"Qiang","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haizhong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-7476","authenticated-orcid":false,"given":"Meng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176278_bib1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2021.05.018","article-title":"Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: a review","volume":"162","author":"Alvarez Secord","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejphar.2023.176278_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-2000-13213","article-title":"Molecular biology of the VEGF and the VEGF receptor family","volume":"26","author":"Clauss","year":"2000","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ejphar.2023.176278_bib3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/bmj.302.6788.1289","article-title":"Physiological importance of nitric oxide","volume":"302","author":"Collier","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2023.176278_bib4","doi-asserted-by":"crossref","first-page":"9566","DOI":"10.3748\/wjg.v21.i32.9566","article-title":"Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway","volume":"21","author":"Ding","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2023.176278_bib5","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1096\/fj.01-0938fje","article-title":"Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole","volume":"16","author":"Faehling","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2023.176278_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2012.03.007","article-title":"Functional aspects on the pathophysiology of portal hypertension in cirrhosis","volume":"57","author":"Garcia-Pagan","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176278_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-022-00366-6","article-title":"Hepatic encephalopathy","volume":"8","author":"Haussinger","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejphar.2023.176278_bib8","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1158\/0008-5472.CAN-07-5809","article-title":"The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis","volume":"68","author":"Heckman","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2023.176278_bib9","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","author":"Hennenberg","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2023.176278_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.585218","article-title":"Detection of cerebrovascular loss in the normal aging C57BL\/6 mouse brain using in vivo contrast-enhanced magnetic resonance angiography","volume":"12","author":"Hill","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2023.176278_bib11","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/hep.27679","article-title":"Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats","volume":"61","author":"Hsu","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2023.176278_bib12","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1582-4934.2011.01399.x","article-title":"Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure","volume":"16","author":"Huang","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2023.176278_bib13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10637-013-9991-2","article-title":"Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study","volume":"31","author":"Hyams","year":"2013","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejphar.2023.176278_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cld.2013.12.001","article-title":"Pathophysiology of portal hypertension","volume":"18","author":"Iwakiri","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejphar.2023.176278_bib15","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2023.176278_bib16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176278_bib17","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy","volume":"3","author":"Iwakiri","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ejphar.2023.176278_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1200\/JCO.21.02947","article-title":"Randomized trial of olaparib with or without cediranib for metastatic castration-resistant prostate cancer: the results from national cancer institute 9984","volume":"41","author":"Kim","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2023.176278_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcmgh.2023.05.010","article-title":"In vivo and in vitro models to study liver fibrosis: mechanisms and limitations","volume":"16","author":"Lee","year":"2023","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176278_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101238","article-title":"L-NAME releases nitric oxide and potentiates subsequent nitroglycerin-mediated vasodilation","volume":"26","author":"Liu","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2023.176278_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12072-017-9826-x","article-title":"Biology of portal hypertension","volume":"12","author":"McConnell","year":"2018","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ejphar.2023.176278_bib22","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.ejphar.2023.176278_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1078-0432.CCR-18-1254","article-title":"The role of angiogenesis in hepatocellular carcinoma","volume":"25","author":"Morse","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2023.176278_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2023.176278_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1749-6632.1994.tb12041.x","article-title":"The role of PECAM-1 in vascular cell biology","volume":"714","author":"Newman","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2023.176278_bib26","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/JTO.0b013e318174e910","article-title":"The tyrosine kinase inhibitor cediranib for non-small cell lung cancer and other thoracic malignancies","volume":"3","author":"Nikolinakos","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejphar.2023.176278_bib27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jhep.2016.07.021","article-title":"Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging","volume":"65","author":"Palaniyappan","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176278_bib28","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1080\/15548627.2020.1834711","article-title":"TXNIP\/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation","volume":"17","author":"Park","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2023.176278_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25184310","article-title":"Effects of combined admistration of Imatinib and Sorafenib in a murine model of liver fibrosis","volume":"25","author":"Pesce","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2023.176278_bib30","first-page":"300","article-title":"New insight into the anti-liver fibrosis effect of multitargeted tyrosine kinase inhibitors: from molecular Target to clinical trials","volume":"6","author":"Qu","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176278_bib31","first-page":"171","article-title":"Activation of dengue virus-specific T cells modulates vascular endothelial growth factor receptor 2 expression","volume":"35","author":"Rattanamahaphoom","year":"2017","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2023.176278_bib32","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1161\/CIR.0000000000000477","article-title":"Management of patients on non-Vitamin K antagonist oral anticoagulants in the Acute care and periprocedural setting: a scientific statement from the American heart association","volume":"135","author":"Raval","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.176278_bib33","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1139\/Y10-064","article-title":"Identification of VEGF receptor-2 tyrosine phosphorylation sites involved in VEGF-mediated endothelial platelet-activating factor synthesis","volume":"88","author":"Rechka","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176278_bib34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.mayocp.2018.12.020","article-title":"Portal hypertension and related complications: diagnosis and Management","volume":"94","author":"Simonetto","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2023.176278_bib35","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1038\/bjc.2013.649","article-title":"Prognostic\/predictive value of 207 serum factors in colorectal cancer treated with cediranib and\/or chemotherapy","volume":"109","author":"Spencer","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2023.176278_bib36","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ejca.2009.12.023","article-title":"Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours","volume":"46","author":"van Cruijsen","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2023.176278_bib37","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/hep.28499","article-title":"Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension","volume":"63","author":"Vilarinho","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2023.176278_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073645","article-title":"Vascular permeability in diseases","volume":"23","author":"Wautier","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.176278_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12864-023-09125-7","article-title":"Transcriptome analysis of mesenteric arterioles changes and its mechanisms in cirrhotic rats with portal hypertension","volume":"24","author":"Wu","year":"2023","journal-title":"BMC Genom."},{"key":"10.1016\/j.ejphar.2023.176278_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1alpha\/SLC7A11 pathway","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ejphar.2023.176278_bib41","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.7150\/ijbs.41293","article-title":"Potential Crosstalk between liver and Extra-liver organs in mouse models of acute liver injury","volume":"16","author":"Zheng","year":"2020","journal-title":"Int. J. Biol. Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923007926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923007926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:24:31Z","timestamp":1762143871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923007926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":41,"alternative-id":["S0014299923007926"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176278","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176278"}}